Drug sales (proportion of the cost per group) for dyspepsia, gastro-oesophageal reflux disease, and “gastritis” in Sweden in 1996; total cost US$170 million67
| Percentage of cost | |
|---|---|
| Antacids/alginates | 6 |
| H2 receptor antagonists | 21 |
| Proton pump inhibitors | 67 |
| Prokinetics | 6 |